Front Page

Inside Pharma 1
Suppliers to the Pharmaceutical Industry: high expectations in a challenging market

Markets & Companies 2-6

Chemical Customer Connectivity Index (C3X) 4
Sustainable Complexity - Or How to Win in a Volatile Market Environment
Tobias Lewe and Marc Vathauer, A.T. Kearney

Driven By Innovation 5
Merck Millipore Merger Prime Example for a Strategic Acquisition
Interview with Dr. Bernd Reckmann, member of the executive board of Merck KGaA

Welcome To Pharma 3.0 6
Part 3: Strengthening support functions to enable business model transformation.
Frank Kumli, Business Analyst, Ernst & Young; Patrick Flochel, EMEIA Life Sciences Leader, Ernst & Young

Reach 7-10

Reach Is Everywhere 7
How to Fulfil Your Commitments to Your Customers under Reach and CLP
Barry Podd, Kimberly Clark Europe

An Appeal For Calm 8
Everyone is on the Learning Curve in Reach
Interview with Peter Brandhofer, head of Reach Department/Quality Management, Helm

A Few More Months 8
The Reach Deadline is Approaching Fast
Annette Elizabeth Ewence, National Centre for Environmental Toxicology, The WRc Group

Reaching Out, Working Together 9
Communication Vital within SIEFs
Mercedes Viña, manager chemical regulations, Cefic

Surviving Purple Fever 10
Navigating the Minefield of Labeling Under The CLP
Fraser Goodey, business consultant, Atrion International

The Persistence of Time 10, 18
With Reach Stealing the Spotlight, Many Have Forgotten About CLP
Andrew Fasey, Founder, Protection Through Knowledge (PTK)


Production 11-14

Time To Update? 11
Control System Migration Strategies
Larry O'Brien, Research Director, Process Automation; Dave Woll, Vice President, Consulting Services

Safe Flow Measurement 12
Corrosive Chemicals Pose Challenges
Rocky Zhang, business development manager, Siemens Industry, Inc.

Waste Not, Want Not 13
Getting on the Cutting Edge of Responsible Pharma Packaging
Kevin Mulligan, PTIS Packaging and Technology Integrated Solutions

In The Matrix 13
France to Use Datamatrix System for Pharma Traceability

Process R&D 14
Chemical Development and Scale Up in the Fine Chemical and Pharmaceutical
Will Watson, Scientific Update

Chemicals 15-27

‘More Talking, Less Walking' 15
CPhI Opens in Paris with a New Layout
Interview with Annemieke Timmers, brand director, CPhI and Haf Cennydd, brand director, ICSE, P-MEC & BioPh

Who's Who in Fine Chemicals 16
An Analysis of the Industry's Top 10 Players
Jan Ramakers, Jan Ramakers Fine Chemical Consulting Group

‘Layer By Layer' 17
Clariant's Streamlining Bears First Fruits
Interview with Patrick Jany, CFO, Clariant

Responding To Change 17
Redefining the Relationship Between Pharma and CMOs
Enrico Polastro, Arthur D. Little

The Cornerstone of Chemistry 18
Evonik's Catalyst Business Sets Technology in Motion
Interview with Dr. Wilfried Eul, senior vice president for catalysts, Evonik

Here To Stay 19
The Significance of Catalysis in the Pharmaceutical Industry
Hans-Jürgen Federsel, senior principal scientist, Astrazeneca

A Reliable Partner 20
Custom Manufacturing is Built on Trust
Interviews with Dr. Andreas Stolle, Head of Business Line Pharma, Saltigo; Dr. Christian Dowdeswell, Sales Director, Dishman Group; Mark Cassidy, Director of Global Sales & Marketing, SAFC ; Roger-Marc Nicoud, President and CEO, Groupe Novasep

The Other Side of the Coin 20
What do companies look for in a custom manufacturer?
Interview with Jörg Decker-Conradi, Bayer Healthcare

Coming Home 21
Fine Chemicals Are Enjoying a European Revival
Interview with Dr. Andreas Meier, Solvay Flour

Here, There, Everywhere 21
Many Companies Offer a Wide Range of Services
Interviews with Dr. Matthias Grehl, Vice President, Umicore

Expect High Performance 22
API Manufacturers Face Many Hurdles in Business
Interview with Dr. Andreas Dietrich, Head of Pharma Chemicals and Business Operations, Boehringer Ingelheim Pharma and Dr. Heinz Sieger, CEO, CU Chemie Uetikon

Securing Each Step 23
Excipients Manufacturers Adhere to Standards and Goals
Interviews with Bodo Fritzsching, Head of Sales & Technical Services Pharma, Beneo-Palatinit; Burghard Freiberg, Senior Vice President Life Science Solution, Merck KGaA; Dermot Pearson, Marketing Director, Novozymes

Complexity Within Biosimilars 24
Gold Mine or a Dead-end for the Generic Industry?
Peter Wittner, Interpharm Consultancy

Imagination Over Experience 25
Exploring new Innovations in High Functionality Excipients
Edmont V. Stoyanov, JRS Pharma

Portfolio Management 26
The Art of Making the Right Choices
Roger Holdsworth, Director - R&D Portfolio Management, UCB

Hot Melt Extrusion Technology 26
Growing importance in Pharmaceutical processing
Vanessa Occhipinti , BASF

Fluctuating Raw Material Prices 27
How to Manage Higher Costs, Inflation and Collapsing Margins
Dr. Andrea Maessen and Karl-Heinz Sebastian, Simon-Kucher & Partners